BTF3P3

Across TCGA pan-cancer cohorts, BTF3P3 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated BTF3P3 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher BTF3P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BTF3P3 expression acts as an unfavorable survival marker, although some lineages such as SKCM and MESO show a favorable association.

KIRC, SKCM, and OV are the cancer types where BTF3P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.508	0.740	<.001	118	view →
SKCM	OS	Median	All	0.827	0.735	<.001	60	view →
OV	OS	Quartile	All	0.257	0.417	.002	48	view →
STAD	DFS	Median	III,IV	0.464	0.682	.003	42	view →
MESO	DFS	Median	II,III,IV	0.726	0.174	<.001	39	view →
COAD	OS	Median	All	0.913	0.822	.002	35	view →
ACC	OS	Median	All	0.475	0.739	.010	29	view →
UCEC	DFS	Quartile	III,IV	0.908	0.701	.006	24	view →
LUSC	OS	Median	All	0.465	0.332	.005	19	view →
PCPG	DFS	Median	All	0.956	0.824	.007	14	view →
LIHC	DFS	Quartile	II,III,IV	0.277	0.507	.012	14	view →
KICH	DFS	Quartile	All	0.785	1.000	.032	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

BTF3P3–KIRC (DFS)

Open the KIRC breakdown →